Exact Sciences Corp
Deschisă
SectorSănătate
104.93
Rezumat
Modificarea prețului
24h
Minim
104.9
Maxim
104.96
Venit | -66M -86M |
|---|---|
Vânzări | 28M 878M |
EPS | -0.21 |
Marjă de profit | -9.786 |
Angajați | 7,100 |
EBITDA | -68M -20M |
Recomandări | Neutru |
|---|---|
Prognoză pe 12 luni | +0.09% upside |
Capitalizare de piață | 404M 20B |
|---|---|
Deschiderea anterioară | 104.93 |
Închiderea anterioară | 104.93 |
Scor tehnic
By Trading Central
Încredere
Strong Bullish Evidence
Exact Sciences Corp Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
Exact Sciences Corp Așteptări
Obiectiv de preț
By TipRanks
0.09% sus
Prognoză pe 12 luni
Medie 105 USD 0.09%
Maxim 105 USD
Minim 105 USD
În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruExact Sciences Corp - Dist în ultimele 3 luni.
Date financiare
$
Despre Exact Sciences Corp
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
